Bristol Myers Squibb CEO Chris Boerner says company culture was missing piece of patent cliff plan
When Chris Boerner became CEO and board chair of Bristol Myers Squibb (No. 94 on the Fortune 500) two years ago, he took over a storied pharmaceutical company with roots in supplying pain medication to Union soldiers on Civil War battlefields. He also arrived at a time when...
